UAE marks World Health Day with AED 3.6B preventive care push across 2,400 primary health centres

The UAE's preventive healthcare spending hit AED 3.6 billion in 2025, or 27% of total health expenditure, as all three regulators now tie screening mandates to financial penalties for non-compliant facilities.

That shift has direct consequences for operators running primary care networks and outpatient facilities. Preventive care reimbursement has expanded under all three regulatory frameworks, and non-compliance with new screening mandates carries real financial penalties.

Where the money is going

The Ministry of Health and Prevention (MOHAP) reported that the UAE's total healthcare expenditure reached AED 13.4 billion in 2025, with preventive programmes absorbing AED 3.6 billion. That share stood at 19% in 2021. The increase follows a federal strategy codified in the National Health Strategy 2021–2031, which set a target of 30% preventive allocation by 2028.

The Dubai Health Authority (DHA) now mandates annual wellness screenings for all insured residents in the emirate, covering cardiovascular risk panels, diabetes markers, and mental health assessments. Facilities that fail to report screening data to DHA's Salama platform face fines starting at AED 10,000 per quarter. The Department of Health Abu Dhabi (DOH) runs a parallel mandate under its Weqaya programme, which has screened more than 1.8 million Abu Dhabi residents since its 2019 relaunch.

Operators face new compliance timelines

COOs and compliance teams should note two deadlines:

• 30 June 2026 — MOHAP's updated Chronic Disease Registry requires all licensed facilities across the Northern Emirates to submit quarterly prevalence data for diabetes, hypertension, and obesity.
• 1 January 2027 — DHA's expanded Dubai Health Insurance Scheme mandates that all basic insurance plans include preventive screening coverage, affecting an estimated 4,200 licensed facilities in the emirate.

For CFOs modelling the impact, DHA data shows that average outpatient visit costs for patients enrolled in preventive screening programmes are 22% lower over a three-year cycle than for unscreened populations, driven by earlier intervention in conditions like Type 2 diabetes and cardiovascular disease. The cost of treating a late-stage diabetic complication runs AED 45,000–62,000 annually, versus AED 8,000–12,000 for managed early-stage care.

Technology and workforce gaps

DHA and DOH both require real-time screening data submission through integrated electronic health records. Facilities still running legacy systems without HL7 FHIR interoperability face integration costs that CIOs estimate at AED 200,000–500,000 per facility, depending on scale. The Abu Dhabi Healthcare Information and Cyber Security Standard, updated in late 2025, adds data protection requirements for all patient screening records transmitted to DOH platforms.

Workforce supply is the second constraint. MOHAP workforce planning data puts the gap at:

• 1,200 additional primary care physicians needed
• 3,400 nurses needed to staff the preventive care expansion at current utilisation rates
• 2,100 Golden Visa applications processed in the programme's first year after its 2025 expansion to general practitioners and specialist nurses

Screening mandates, reimbursement shifts, and data reporting requirements are already on compliance calendars. Facilities that treat preventive care as a cost centre rather than a revenue line will find the economics working against them within 18 months.